Nisa Investment Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-3
| Closed | -$43 | – | 3009 |
|
2024
Q2 | $43 | Sell |
3
-10
| -77% | -$143 | ﹤0.01% | 2908 |
|
2024
Q1 | $305 | Buy |
+13
| New | +$305 | ﹤0.01% | 2580 |
|
2023
Q4 | – | Sell |
-53
| Closed | -$1.07K | – | 2691 |
|
2023
Q3 | $1.07K | Hold |
53
| – | – | ﹤0.01% | 2388 |
|
2023
Q2 | $1.43K | Sell |
53
-4
| -7% | -$108 | ﹤0.01% | 2389 |
|
2023
Q1 | $3K | Buy |
57
+4
| +8% | +$211 | ﹤0.01% | 2286 |
|
2022
Q4 | $3K | Sell |
53
-327
| -86% | -$18.5K | ﹤0.01% | 2340 |
|
2022
Q3 | $26K | Buy |
380
+327
| +617% | +$22.4K | ﹤0.01% | 1979 |
|
2022
Q2 | $4K | Hold |
53
| – | – | ﹤0.01% | 2297 |
|
2022
Q1 | $6K | Hold |
53
| – | – | ﹤0.01% | 2287 |
|
2021
Q4 | $7K | Hold |
53
| – | – | ﹤0.01% | 2068 |
|
2021
Q3 | $5 | Hold |
53
| – | – | ﹤0.01% | 2257 |
|
2021
Q2 | $8 | Sell |
53
-217
| -80% | -$33 | ﹤0.01% | 2248 |
|
2021
Q1 | $43 | Hold |
270
| – | – | ﹤0.01% | 2008 |
|
2020
Q4 | $63K | Buy |
270
+37
| +16% | +$8.63K | ﹤0.01% | 1921 |
|
2020
Q3 | $51K | Buy |
233
+176
| +309% | +$38.5K | ﹤0.01% | 1798 |
|
2020
Q2 | $16K | Buy |
57
+18
| +46% | +$5.05K | ﹤0.01% | 1825 |
|
2020
Q1 | $11K | Buy |
+39
| New | +$11K | ﹤0.01% | 1836 |
|